CTYPE html> BacVacDB | Bacterial Diseases

Browse By Bacterial Diseases

This page shows data for E.coli Infections disease.
Total Entries Retrieved: 12
IDName of the vaccineDisease nameName of bacteriaType of vaccineName of the manufacturerClinical Phase statusRoute of administrationPubMed identifierClinical trial number
1210 EcoXyn-4V E.coli Infections Escherichia coli Bioconjugate GlycoVaxyn AG Clinical - Phase 1 Intramuscular NA NCT02289794
1211 Recombinant (dsc14CfaE-sCT2/LTB5) E.coli Infections Escherichia coli Recombinant U.S. Army Medical Research and Development Command Clinical - Phase 1 Intradermal NA NCT01644565
1212 Recombinant (dscCfaE) E.coli Infections Escherichia coli Recombinant U.S. Army Medical Research and Development Command Clinical - Phase 1 Transcutaneous NA NCT01382095
1213 CVD 1208S-122 E.coli Infections Escherichia coli Live attenuated University of Maryland, Baltimore Clinical - Phase 1 Oral 32257392 NCT04634513
1214 VLA1701 E.coli Infections Escherichia coli NA Valneva Austria GmbH Clinical - Phase 2 Oral NA NCT03576183
1215 dmLT E.coli Infections Escherichia coli Recombinant National Institute of Allergy and Infectious Diseases (NIAID) Clinical - Phase 1 Sublingual NA NCT02052934
1216 ACE527 E.coli Infections Escherichia coli Live attenuated TD Vaccines A/S Clinical - Phase 1 Oral NA NCT00901654
1217 ExPEC9V E.coli Infections Escherichia coli Bioconjugate Janssen Research & Development, LLC Clinical - Phase 3 Intramuscular NA NCT04899336
1218 ACAM2007 E.coli Infections Escherichia coli Live attenuated NA Clinical - Phase 1 Oral 17566016 NA
1219 ACAM2010 E.coli Infections Escherichia coli Live attenuated NA Clinical - Phase 1 Oral 17566016 NA
1220 ACAM2017 E.coli Infections Escherichia coli Live attenuated NA Clinical - Phase 1 Oral 17566016 NA
1221 ETEC expressing CFA/I and CFA/II E.coli Infections Escherichia coli Inactivated NA Clinical Oral NA NA